Patents by Inventor Joshua Schultz

Joshua Schultz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7486081
    Abstract: A mobile apparatus for monitoring an electric field in a patrolled area, comprising at least one detection device for measuring electric field signals, at least one camera device for collecting video images of said patrolled area, a processor for correlating video image data collected from the camera device with electric field signal data measured by the detection device, and a video based graphical user interface for analyzing and capturing a monitored event depicting an anomaly in the measured electric field signals.
    Type: Grant
    Filed: October 19, 2006
    Date of Patent: February 3, 2009
    Assignee: Power Survey LLC
    Inventors: David Kalokitis, Leonard Joshua Schultz, Christos A. Polyzois, Vincent Paragano
  • Publication number: 20080009608
    Abstract: The present invention provides nucleic acids encoding a novel ABC family cholesterol transporter, SSG. The herein-disclosed sequences can be used for any of a number of purposes, including for the diagnosis and treatment of cholesterol-associated disorders, including sitosterolemia, and for the identification of molecules that associate with and/or modulate the activity of SSG.
    Type: Application
    Filed: December 27, 2006
    Publication date: January 10, 2008
    Applicant: Amgen Inc.
    Inventors: Hui Tian, Joshua Schultz, Bei Shan
  • Patent number: 7229816
    Abstract: The present invention provides polypeptides of a novel ABC family cholesterol transporter, SSG. The herein-disclosed sequences can be used for any of a number of purposes, including for the diagnosis and treatment of cholesterol-associated disorders, including sitosterolemia, and for the identification of molecules that associate with and/or modulate the activity of SSG.
    Type: Grant
    Filed: May 11, 2005
    Date of Patent: June 12, 2007
    Assignee: Amgen Inc.
    Inventors: Hui Tian, Joshua Schultz, Bei Shan
  • Patent number: 7033810
    Abstract: The present invention provides nucleic acids encoding a novel ABC family cholesterol transporter, SSG. The herein-disclosed sequences can be used for any of a number of purposes, including for the diagnosis and treatment of cholesterol-associated disorders, including sitosterolemia, and for the identification of molecules that associate with and/or modulate the activity of SSG.
    Type: Grant
    Filed: April 18, 2001
    Date of Patent: April 25, 2006
    Assignee: Amgen Inc.
    Inventors: Hui Tian, Joshua Schultz, Bei Shan
  • Publication number: 20050214850
    Abstract: The present invention provides polypeptides of a novel ABC family cholesterol transporter, SSG. The herein-disclosed sequences can be used for any of a number of purposes, including for the diagnosis and treatment of cholesterol-associated disorders, including sitosterolemia, and for the identification of molecules that associate with and/or modulate the activity of SSG.
    Type: Application
    Filed: May 11, 2005
    Publication date: September 29, 2005
    Applicant: Tularik Inc.
    Inventors: Hui Tian, Joshua Schultz, Bei Shan
  • Publication number: 20020081687
    Abstract: The present invention provides nucleic acids encoding a novel ABC family cholesterol transporter, SSG. The herein-disclosed sequences can be used for any of a number of purposes, including for the diagnosis and treatment of cholesterol-associated disorders, including sitosterolemia, and for the identification of molecules that associate with and/or modulate the activity of SSG.
    Type: Application
    Filed: April 18, 2001
    Publication date: June 27, 2002
    Inventors: Hui Tian, Joshua Schultz, Bei Shan
  • Publication number: 20020048572
    Abstract: This invention provides methods for identifying compounds that are suitable for use in modulating fatty acid and triglyceride biosynthesis, and thus treating conditions such as hypertriglyceridemia and lipodystrophy, among others. Provided are in vitro assays by which one can conduct prescreening to identify candidate therapeutic agents that are suitable for further testing, as well as assays for identifying agents that are useful for administration for treating conditions associated with abnormalities in fatty acid and triglyceride biosynthesis.
    Type: Application
    Filed: May 3, 2001
    Publication date: April 25, 2002
    Inventors: Bei Shan, Joshua Schultz, Hua Tu